Identification of a T cell-derived b cell growth factor distinct from interleukin 2.
Authors
Discussion
Loading...
Member takes
Implication
Experimental study identifies a T cell-derived B cell growth factor that drives proliferation in murine B lymphocytes, demonstrating a distinct signaling pathway independent of interleukin 2.
Key Points
- To identify and characterize a novel T cell-derived growth factor that stimulates B lymphocyte proliferation independently of interleukin 2.
- Assayed culture supernatants from stimulated murine thymoma EL4 cells using short-term in vitro cultures of purified B lymphocytes co-stimulated with anti-IgM antibodies.
- Evaluated molecular weight and absorption profiles to differentiate the factor biochemically from interleukin 2.
- Tested cooperative interactions between the factor, antigen, interleukin 2, and T cell-replacing factor in generating erythrocyte-specific plaque-forming cells.
- The B cell growth factor co-stimulated with anti-IgM antibodies to drive polyclonal B cell proliferation in a non-H-2-restricted manner without triggering antibody-forming cell production.
- Absorption assays and molecular weight determination confirmed that the growth factor is biologically and biochemically distinct from interleukin 2.
- Co-administration of the growth factor with antigen, interleukin 2, and T cell-replacing factor successfully induced erythrocyte-specific plaque-forming cell formation in purified B cell cultures.
Cite This Study
Howard et al. (1982) studied this question.